5767-84-0Relevant articles and documents
EXTRAHEPATIC DELIVERY
-
Paragraph 0566; 0706, (2021/05/15)
One aspect of the present invention relates to a compound comprising an antisense strand which is complementary to a target gene; a sense strand which is complementary to said antisense strand; and one or more lipophilic monomers, containing one or more lipophilic moieties, conjugated to one or more positions on at least one strand, optionally via a linker or carrier. Another aspect of the invention relates to a method of gene silencing, comprising administering to a cell or a subject in need thereof a therapeutically effective amount of the lipophilic monomer-conjugated compound.
ABSORBABLE BRANCHED POLYESTERS AND POLYURETHANES
-
Paragraph 0166-0168, (2014/05/25)
The present invention relates to the discovery of a new class of hydrolysable isocyanates, hydrolysable branched polyols and branched absorbable polyesters and polyurethanes prepared therefrom. The resultant absorbable polymers are useful for drug delivery, stents, highly porous foam, reticulated foam, tissue engineering, tissue adhesives, adhesion prevention, bone wax formulations, medical device coatings, surface modifying agents and other implantable medical devices. In addition, these absorbable polymers can have a controlled hydrolytic degradation profile.
Chemical and physicochemical properties of the pregna-1,4-diene-3,20-dione-11(beta),17(alpha)-triol-21-stearoylglycolate.
Giraldi,Tosolini,Nannini,Fojanesi
, p. 162 - 164 (2007/10/12)
-
